ANTIPSYCHOTIC ACTIVITY OF 1,2-BENZISOTHIAZOLE ANALOGS OF THE POTENTIAL ATYPICAL ANTIPSYCHOTIC ILOPERIDONE (HP873)

被引：0
作者：
STRUPCZEWSKI, JT [1 ]
BORDEAU, KJ [1 ]
GLAMKOWSKI, EJ [1 ]
FINK, DM [1 ]
BREGNA, DE [1 ]
CORBETT, R [1 ]
HARTMAN, HB [1 ]
ROEHR, JE [1 ]
SZEWCZAK, MR [1 ]
WOODS, AT [1 ]
机构：
[1] HOECHST ROUSSEL PHARMACEUT PROPRIETARY LTD,NEUROSCI PROD GRP UNIT,SOMERVILLE,NJ 08876
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 210卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：138 / MEDI
相关论文
共 50 条
  • [41] Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex:: role of 5-HT1A receptor agonism
    Ichikawa, J
    Li, Z
    Dai, J
    Meltzer, HY
    BRAIN RESEARCH, 2002, 956 (02) : 349 - 357
  • [42] 3-Aminomethyl Derivatives of 2-Phenylimidazo[1,2-a]-pyridine as Positive Allosteric Modulators of GABAA Receptor with Potential Antipsychotic Activity
    Marcinkowska, Monika
    Kolaczkowski, Marcin
    Kaminski, Krzysztof
    Bucki, Adam
    Pawlowski, Maciej
    Siwek, Agata
    Karcz, Tadeusz
    Starowicz, Gabriela
    Sloczynska, Karolina
    Pekala, Elzbieta
    Wesolowska, Anna
    Samochowiec, Jerzy
    Mierzejewski, Pawel
    Bienkowski, Przemyslaw
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (06): : 1291 - 1298
  • [43] Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity:: Role in atypical antipsychotic action
    Díaz-Mataix, L
    Scorza, MC
    Bortolozzi, A
    Toth, M
    Celada, P
    Artigas, F
    JOURNAL OF NEUROSCIENCE, 2005, 25 (47) : 10831 - 10843
  • [44] Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
    Hattori, Saki
    Suda, Akira
    Kishida, Ikuko
    Miyauchi, Masatoshi
    Shiraishi, Yohko
    Fujibayashi, Mami
    Tsujita, Natsuki
    Ishii, Chie
    Ishii, Norio
    Moritani, Toshio
    Taguri, Masataka
    Hirayasu, Yoshio
    BMC PSYCHIATRY, 2018, 18
  • [45] ATYPICAL ANTIPSYCHOTIC AGENTS - PATTERNS OF ACTIVITY IN A SERIES OF 3-SUBSTITUTED 2-PYRIDINYL-1-PIPERAZINE DERIVATIVES
    NEW, JS
    YEVICH, JP
    TEMPLE, DL
    NEW, KB
    GROSS, SM
    SCHLEMMER, RF
    EISON, MS
    TAYLOR, DP
    RIBLET, LA
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (03) : 618 - 624
  • [46] Atypical antipsychotic profile of BTS 79 018 may be mediated by central 5-HT1A agonist activity
    Needham, PL
    Gross, G
    Wicke, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U90 - U90
  • [47] Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia
    Saki Hattori
    Akira Suda
    Ikuko Kishida
    Masatoshi Miyauchi
    Yohko Shiraishi
    Mami Fujibayashi
    Natsuki Tsujita
    Chie Ishii
    Norio Ishii
    Toshio Moritani
    Masataka Taguri
    Yoshio Hirayasu
    BMC Psychiatry, 18
  • [48] SEROTONIN 5-HT2A, DOPAMINE D2 AND NORADRENALINE ALPHA-1 ANTAGONISTS - ANALOGS OF THE ATYPICAL ANTIPSYCHOTIC SERTINDOLE
    ANDERSEN, K
    PERREGAARD, J
    LILJEFORS, T
    HYTTEL, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 130 - MEDI
  • [49] Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
    Bjørn H Ebdrup
    Filip K Knop
    Pelle L Ishøy
    Egill Rostrup
    Birgitte Fagerlund
    Henrik Lublin
    Birte Glenthøj
    BMC Medicine, 10
  • [50] Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
    Ebdrup, Bjorn H.
    Knop, Filip K.
    Ishoy, Pelle L.
    Rostrup, Egill
    Fagerlund, Birgitte
    Lublin, Henrik
    Glenthoj, Birte
    BMC MEDICINE, 2012, 10
12345